BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci 2021. [PMID: 34671854 DOI: 10.1007/s10072-021-05679-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Rabaan AA, Smajlović S, Tombuloglu H, Ćordić S, Hajdarević A, Kudić N, Al Mutai A, Turkistani SA, Al-Ahmed SH, Al-Zaki NA, Al Marshood MJ, Alfaraj AH, Alhumaid S, Al-Suhaimi E. SARS-CoV-2 infection and multi-organ system damage: A review. Biomol Biomed 2023;23:37-52. [PMID: 36124445 DOI: 10.17305/bjbms.2022.7762] [Reference Citation Analysis]
2 Carpenter KC, Yang J, Xu JJ. Animal Models for the Study of Neurologic Manifestations Of COVID-19. Comp Med 2023;73:91-103. [PMID: 36744556 DOI: 10.30802/AALAS-CM-22-000073] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yoshimura K, Okada Y, Toya S, Asami T, Iwasaki S. Morphological aspect of the angiotensin-converting enzyme 2. Angiotensin 2023. [DOI: 10.1016/b978-0-323-99618-1.00008-8] [Reference Citation Analysis]
4 Aghajani Shahrivar A, Khakpourian Z, Majdi F, Sobhani S, Coleman-fuller N, Gholami M, Motaghinejad M. Hypothesized neuroprotective effect of minocycline against COVID-19-induced stroke and neurological dysfunction: possible role of matrix metalloprotease signaling pathway. Biologia. [DOI: 10.1007/s11756-022-01162-z] [Reference Citation Analysis]
5 Zarifkar P, Peinkhofer C, Benros ME, Kondziella D. Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia. Front Neurol 2022;13:904796. [DOI: 10.3389/fneur.2022.904796] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Zaini M, Abu Farha R, Abutayeh R, Alsaud W, Hammoudeh A, Al-shudifat A, Al-kharabsheh T. Assessment of Jordanian physicians’ knowledge about venous thromboembolism risk and management among COVID-19 patients. Journal of Pharmaceutical Health Services Research 2022. [DOI: 10.1093/jphsr/rmac021] [Reference Citation Analysis]
7 Francesca P, Mauro P, Clerbaux LA, Leoni G, Ponti J, Bogni A, Brogna C, Cristoni S, Sanges R, Mendoza-de Gyves E, Fabbri M, Querci M, Soares H, Munoz Pineiro A, Whelan M, Van de Eede G. Effects of spike protein and toxin-like peptides found in COVID-19 patients on human 3D neuronal/glial model undergoing differentiation: possible implications for SARS-CoV-2 impact on brain development. Reprod Toxicol 2022:S0890-6238(22)00060-0. [PMID: 35525527 DOI: 10.1016/j.reprotox.2022.04.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Rubakova AA, Lebedeva JI, Turovina EF, I SC, Khasanova LT, Suvorov AJ, Kazakova ZD. [Clinical and pathophysiological features of stroke in patients with COVID-19]. Zh Nevrol Psikhiatr Im S S Korsakova 2022;122:26-32. [PMID: 36582158 DOI: 10.17116/jnevro202212212226] [Reference Citation Analysis]
9 Rakhmatullin A, Kutlubaev M. An analysis of clinical and laboratory characteristics of patients with ischemic stroke and COVID-19. Z nevrol psikhiatr im S S Korsakova 2022;122:34. [DOI: 10.17116/jnevro202212211234] [Reference Citation Analysis]